ProfileGDS5678 / 1425740_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 23% 25% 24% 26% 26% 23% 23% 25% 25% 25% 24% 24% 24% 25% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5688723
GSM967853U87-EV human glioblastoma xenograft - Control 22.5711925
GSM967854U87-EV human glioblastoma xenograft - Control 32.5643824
GSM967855U87-EV human glioblastoma xenograft - Control 42.545926
GSM967856U87-EV human glioblastoma xenograft - Control 52.5542326
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.609623
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5668223
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.5545525
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.5508925
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.56325
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.5573924
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.5317824
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5623824
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.5671825